Dacomitinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: A cost-effectiveness analysis

  1. Aguilar-Serra, J.
  2. Gimeno-Ballester, V.
  3. Pastor-Clerigues, A.
  4. Milara, J.
  5. Marti-Bonmati, E.
  6. Trigo-Vicente, C.
  7. Cortijo, J.
Aldizkaria:
Journal of Comparative Effectiveness Research

ISSN: 2042-6313,  2042-6305

Argitalpen urtea: 2021

Alea: 10

Zenbakia: 4

Orrialdeak: 325-335

Mota: Artikulua

DOI: 10.2217/CER-2020-0233 GOOGLE SCHOLAR
Datuen iturria: Scopus